Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-20-028068
Filing Date
2020-12-11
Accepted
2020-12-10 21:22:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 nt10017732x4_424b5.htm 424B5 488504
2 logo_rocketpharma.jpg GRAPHIC 36798
  Complete submission text file 0001140361-20-028068.txt   540115
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-232168 | Film No.: 201382015
SIC: 2834 Pharmaceutical Preparations